Class IITerminatedD-0377-2021
Drug recall · May 26, 2021
Metoclopramide Injection USP recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04
- Lots / codes
Lot # 31325459B, exp. date 08/2021
- Quantity
- 3,138/25 single use vials per tray
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Product was distributed nationwide.
- Initiated
- April 26, 2021 · Voluntary: Firm initiated
- Classified
- May 14, 2021
- Reported
- May 26, 2021
- Ended
- June 4, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedMay 26, 2021Leucovorin Calcium for InjectionTeva Pharmaceuticals USA · D-0374-2021Class IITerminatedMay 26, 2021Haloperidol Decanoate InjectionTeva Pharmaceuticals USA · D-0375-2021Class IITerminatedMay 26, 2021Methylprednisolone Acetate Injectable Suspension USPTeva Pharmaceuticals USA · D-0376-2021Class IITerminatedMay 26, 2021Haloperidol Decanoate InjectionTeva Pharmaceuticals USA · D-0378-2021
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoclopramide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.